drugset / Trial / NCT01052623

Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

NCT01052623

Phase 4 Unknown 24 enrolled Johann Wolfgang Goethe University Hospital
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study will evaluate the status of the growth hormone/ insulin-like growth factor-1 (GH/IGF-1) axis in relation to growth failure, body weight and composition and neuroprotection in children with Ataxia telangiectasia (AT).

Timeline

Start
2010-01
Primary completion
2011-12
Completion
2012-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 0.075 mg/m2 Oral
Subject L-Arginin-Hydrochloride Unknown 0.5 g/kg Intravenous
Subject Somatropin Protein / enzyme biologic 0.03 mg/kg Subcutaneous
Background estradiol valerate Unknown 1 mg Oral

Indications